Oxidative stress: Emerging mitochondrial and cellular themes and variations in neuronal injury

Journal of Alzheimer's Disease

Volumn 20, Issue SUPPL.2, 2010, Pages

  Higgins, Gavin C ^a   Beart, Philip M ^b   Shin, Yea Seul ^b   Chen, Minghui Jessica ^c   Cheung, Nam Sang ^c   Nagley, Phillip ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Apoptosis; autophagy; mitochondria; necrosis; neurodegeneration; neurons; oxidative stress; programmed cell death

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTIMYCIN A1; CALCYCLIN; CYTOCHROME B5 REDUCTASE; FK 506 BINDING PROTEIN; GLUTATHIONE TRANSFERASE; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; HYPOCHLOROUS ACID; ISOCITRATE DEHYDROGENASE; MYELOPEROXIDASE; NITRIC OXIDE SYNTHASE; POTASSIUM CYANIDE; PROTEIN KINASE C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ROTENONE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; UBIQUITIN CONJUGATING ENZYME E2;

ALZHEIMER DISEASE; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; AUTOPHAGY; CALCIUM BINDING; CALCIUM HOMEOSTASIS; CELL ACTIVITY; CELL COUNT; CELL DEATH; CELL FUNCTION; CELL LEVEL; CELL ORGANELLE; CELL TYPE; CELL VIABILITY; CELLULAR DISTRIBUTION; CELLULAR STRESS RESPONSE; ENDOPLASMIC RETICULUM; HUMAN; MITOCHONDRION; NERVE CELL; NERVE CELL LESION; NEUROPATHOLOGY; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; RESPIRATORY CHAIN; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS;

EID: 77956207696     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100321     Document Type: Review

References (165)

1. Jenner P (2007) Oxidative stress and Parkinson's disease. Handb Clin Neurol 83, 507-520.
2. Pratico D (2008) Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy. AnnN YAcad Sci 1147, 70-78.
3. Crack PJ, Taylor JM (2005) Reactive oxygen species and the modulation of stroke. Free Radic Biol Med 38, 1433-1444.
4. Cooper AJL (1997) Glutathione in the brain: disorders of glu-tathione metabolism In The Molecular and Genetic Basis of Neurological Disease, Rosenberg RN, Prusiner SB, Di Mau-ro S, Barchi RL, Kunk LM, eds., Butterworth-Heinemann, Boston, pp. 1195-1230.
5. Koutsilieri E, Scheller C, Tribl F, Riederer P (2002) Degeneration of neuronal cells due to oxidative stress -microglial contribution. Parkinsonism Relat Disord 8, 401-406.
6. Andersen JK (2004) Oxidative stress in neurodegeneration: cause or consequence? Nat Med 10 Suppl, S18-25.
7. Lenaz G, Bovina C, D'Aurelio M, Fato R, Formiggini G, Genova ML, Giuliano G, Merlo Pich M, Paolucci U, Par-enti Castelli G, Ventura B (2002) Role of mitochondria in oxidative stress and aging. Ann N YAcad Sci 959, 199-213.
8. McLennan HR, Degli Esposti M (2000) The contribution of mitochondrial respiratory complexes to the production of reactive oxygen species. JBioenerg Biomembr 32, 153-162.
9. Sayre LM, Perry G, Smith MA (2008) Oxidative stress and neurotoxicity. Chem Res Toxicol 21, 172-188.
10. Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97, 1634-1658.
11. Shivakumar BR, Anandatheerthavarada HK, Ravindranath V (1991) Free radical scavenging systems in developing rat brain. Int JDev Neurosci 9, 181-185.
12. Hussain S, Slikker W, Jr., Ali SF (1995) Age-related changes in antioxidant enzymes, superoxide dismutase, catalase, glu-tathione peroxidase and glutathione in different regions of mouse brain. Int J Dev Neurosci 13, 811-817.
13. Sohal RS, Sohal BH, BrunkUT(1990) Relationship between antioxidant defenses and longevity in different mammalian species. Mech Ageing Dev 53, 217-227.
14. Dringen R, Kussmaul L, Gutterer JM, Hirrlinger J, Ham-precht B (1999) The glutathione system of peroxide detoxification is less efficient in neurons than in astroglial cells. J Neurochem 72, 2523-2530.
15. Siu AW, Reiter RJ, To CH (1998) The efficacy of vitamin E and melatonin as antioxidants against lipid peroxidation in rat retinal homogenates. J Pineal Res 24, 239-244.
16. Dringen R, Hirrlinger J (2003) Glutathione pathways in the brain. Biol Chem 384, 505-516.
17. Dringen R, Pfeiffer B, Hamprecht B (1999) Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J Neurosci 19, 562-569.
18. Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408, 239-247.
19. Yap Y, Whiteman M, Cheung N (2007) Chlorinative stress: An under appreciated mediator of neurodegeneration? Cell Signal 19, 219-228.
20. Benveniste E (1997) Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. JMolMed 75, 165-173.
21. Tahara EB, Navarete FD, Kowaltowski AJ (2009) Tissue-, substrate-, and site-specific characteristics of mitochondrial reactive oxygen species generation. Free Radic Biol Med 46, 1283-1297.
22. Gu Z, Nakamura T, Lipton SA (2010) Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Mol Neurobiol, in press.
23. Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417, 1-13.
24. Devi L, Anandatheerthavarada HK (2010) Mitochondrial trafficking of APP and alpha synuclein: Relevance to mi-tochondrial dysfunction in Alzheimer's and Parkinson's diseases. Biochim Biophys Acta 1802, 11-19.
25. Balaban RS, Nemoto S, Finkel T (2005) Mitochondria, oxi-dants, and aging. Cell 120, 483-495.
26. Droge W, Schipper HM (2007) Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell 6, 361370.
27. Crack PJ, Cimdins K, Ali U, Hertzog PJ, Iannello RC (2006) Lack of glutathione peroxidase-1 exacerbates Abeta-mediated neurotoxicity in cortical neurons. J Neural Transm 113, 645-657.
28. de Haan JB, Bladier C, Griffiths P, Kelner M, O'Shea RD, Cheung NS, Bronson RT, Silvestro MJ, Wild S, Zheng SS, Beart PM, Hertzog PJ, Kola I (1998) Mice with a homozy-gous null mutation for the most abundant glutathione per-oxidase, Gpx1, show increased susceptibility to the oxida-tive stress-inducing agents paraquat and hydrogen peroxide. J Biol Chem 273, 22528-22536.
29. Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K, Perl-mutter JS, Reich S, Stern M, Watts RL, Kurlan R, Molho E, Harrison M, Lew M (2002) Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol 59, 1541-1550.
30. Nagley P, Higgins GC, Atkin JD, Beart PM (2010) Mul-tifaceted deaths orchestrated by mitochondria in neurones. Biochim Biophys Acta 1802, 167-185.
31. Hyun DH, Gray DA, Halliwell B, Jenner P (2004) Interference with ubiquitination causes oxidative damage and increased protein nitration: implications for neurodegenerative diseases. J Neurochem 90, 422-430.
32. Kroemer G, Galluzzi L, Brenner C (2007) Mitochondrial membrane permeabilization in cell death. Physiol Rev 87, 99-163.
33. Smith DJ, Ng H, Kluck RM, Nagley P (2008) The mitochondrial gateway to cell death. IUBMB Life 60, 383-389.
34. Starkov AA, Chinopoulos C, Fiskum G (2004) Mitochondrial calcium and oxidative stress as mediators of ischemic brain injury. Cell Calcium 36, 257-264.
35. Toescu EC, Verkhratsky A (2003) Neuronal ageing from an intraneuronal perspective: roles of endoplasmic reticulum and mitochondria. Cell Calcium 34, 311-323.
36. Camello-Almaraz C, Gomez-Pinilla PJ, Pozo MJ, Camello PJ (2006) Mitochondrial reactive oxygen species and Ca2+ signaling. Am J Physiol Cell Physiol 291, C1082-C1088.
37. Starkov AA, Polster BM, Fiskum G (2002) Regulation of hydrogen peroxide production by brain mitochondria by calcium and Bax. J Neurochem 83, 220-228.
38. Rizzuto R, Pozzan T (2006) Microdomains of intracellular Ca2+: molecular determinants andfunctional consequences. Physiol Rev 86, 369-408.
39. Nixon RA (2007) Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci 120, 4081-4091.
40. Reddy PH (2009) Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease. Exp Neurol 218, 286-292.
41. Takahashi K, Niidome T, Akaike A, Kihara T, Sugimoto H (2009) Amyloid precursor protein promotes endoplasmic reticulum stress-induced cell death via C/EBP homologous protein-mediated pathway. J Neurochem 109, 1324-1337.
42. Cheung NS, Pascoe CJ, Giardina SF, John CA, Beart PM (1998) Micromolar L-glutamate induces extensive apoptosis in an apoptotic-necrotic continuum of insult-dependent, ex-citotoxic injury in cultured cortical neurones. Neuropharma-cology 37, 1419-1429.
43. Blomgren K, Leist M, Groc L (2007) Pathological apoptosis in the developing brain. Apoptosis 12, 993-1010.
44. Degterev A, Yuan J (2008) Expansion and evolution of cell death programmes. Nat Rev Mol Cell Biol 9, 378-390.
45. Gill MB, Perez-Polo JR (2008) Hypoxia ischemia-mediated cell death in neonatal rat brain. Neurochem Res 33, 23792389.
46. Diwakarla S, Nagley P, Hughes ML, Chen B, Beart PM (2009) Differential insult-dependent recruitment of the intrinsic mitochondrial pathway during neuronal programmed cell death. Cell Mol Life Sci 66, 156-172.
47. Shin YS, Chu PW, Mercer LD, Higgins GC, O'Shea RD, Nagley P, Beart PM (2009) Mitochondrial injury and programmed cell death inducing apoptosis, autophagy and en-doplasmic reticulum stress in neuronal injury. J Neurochem 110, 41.
48. Liu Y, Schubert DR (2009) The specificity of neuroprotection by antioxidants. JBiomed Sci 16, 98.
49. Gibson GE, Starkov A, Blass JP, Ratan RR, Beal MF (2010) Cause and consequence: Mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases. Biochim Biophys Acta 1802, 122-134.
50. Moreira PI, Carvalho C, Zhu X, Smith MA, Perry G (2010) Mitochondrial dysfunction is a trigger ofAlzheimer's disease pathophysiology. Biochim Biophys Acta 1802, 2-10.
51. Smith MA, ZhuX, Tabaton M, Liu G, McKeel DW, Jr., Cohen ML, Wang X, Siedlak SL, Dwyer BE, Hayashi T, Nakamura M, Nunomura A, Perry G (2010) Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J Alzheimers Dis 19, 363-372.
52. de la Monte SM, Sohn YK, Wands JR (1997) Correlates of p53-and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J Neurol Sci 152, 73-83.
53. Jesionek-Kupnicka D, Buczynski J, Kordek R, Sobow T, Kloszewska I, Papierz W, Liberski PP (1997) Programmed cell death (apoptosis) in Alzheimer's disease and Creutzfeldt-Jakob disease. Folia Neuropathol 35, 233-235.
54. Stadelmann C, Bruck W, Bancher C, Jellinger K, Lassmann H (1998) Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J Neu-ropathol Exp Neurol 57, 456-464.
55. Su JH, Deng G, Cotman CW (1997) Bax protein expression is increased in Alzheimer's brain: correlations with DNA damage, Bcl-2 expression, and brain pathology. J Neuropathol Exp Neurol 56, 86-93.
56. Cataldo AM, Hamilton DJ, Barnett JL, Paskevich PA, Nixon RA (1996) Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J Neurosci 16, 186-199.
57. Cheung YT, Zhang NQ, Hung CH, Lai CS, Yu MS, So KF, Chang RC (2009) Temporal relationship of autophagy and apoptosis in neurons challenged by low molecular weight beta-amyloid peptide. J Cell Mol Med, in press.
58. Hung SY, Huang WP, Liou HC, Fu WM (2009) Autophagy protects neuron from Abeta-induced cytotoxicity. Autophagy 5, 502-510.
59. Pickford F, Masliah E, Britschgi M, Lucin K, Narasimhan R, Jaeger PA, Small S, Spencer B, Rockenstein E, Levine B, Wyss-Coray T (2008) The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest 118, 2190-2199.
60. Yang DS, Kumar A, Stavrides P, Peterson J, Peterhoff CM, Pawlik M, Levy E, Cataldo AM, Nixon RA (2008) Neuronal apoptosis and autophagy cross talk in aging PS/APP mice, a model of Alzheimer's disease. Am J Pathol 173, 665-681.
61. Banerjee R, Starkov AA, Beal MF, Thomas B (2009) Mito-chondrial dysfunction in the limelight of Parkinson's disease pathogenesis. Biochim Biophys Acta 1792, 651-663.
62. Iuso A, Scacco S, Piccoli C, Bellomo F, Petruzzella V, Trentadue R, Minuto M, Ripoli M, Capitanio N, Zeviani M, Papa S (2006) Dysfunctions of cellular oxidative metabolism in patients with mutations in the NDUFS1 and NDUFS4 genes of complex I. J Biol Chem 281, 10374-10380.
63. Chu CT, Zhu JH, Cao G, Signore A, Wang S, Chen J (2005) Apoptosis inducing factor mediates caspase-independent 1-methyl-4-phenylpyridinium toxicity in dopaminergic cells. J Neurochem 94, 1685-1695.
64. Lim ML, Mercer LD, Nagley P, Beart PM (2007) Rotenone and MPP+ preferentially redistribute apoptosis-inducing factor in apoptotic dopamine neurons. Neuroreport 18, 307312.
65. Chinta SJ, Rane A, Yadava N, Andersen JK, Nicholls DG, Polster BM (2009) Reactive oxygen species regulation by AIF-and complex I-depleted brain mitochondria. Free Radic Biol Med 46, 939-947.
66. Benit P, Goncalves S, Dassa EP, Briere JJ, Rustin P (2008) The variability of the harlequin mouse phenotype resembles that of human mitochondrial-complex I-deficiency syndromes. PLoS One 3, e3208.
67. Tinsley RB, Bye CR, Parish CL, Tziotis-Vais A, George S, Culvenor JG, Li QX, Masters CL, Finkelstein DI, Horne MK (2009) Dopamine D2 receptor knockout mice develop features of Parkinson disease. Ann Neurol 66, 472-484.
68. Levy OA, Malagelada C, Greene LA (2009) Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps. Apoptosis 14, 478-500.
69. Cocheme HM, Murphy MP (2009) Chapter 22 The uptake and interactions of the redox cycler paraquat with mitochondria. Methods Enzymol 456, 395-417.
70. Drechsel DA, Patel M (2009) Differential contribution of the mitochondrial respiratory chain complexes to reactive oxygen species production by redox cycling agents implicated in parkinsonism. Toxicol Sci 112, 427-434.
71. Choi WS, Kruse SE, Palmiter RD, Xia Z (2008) Mitochon-drial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat. Proc Natl Acad Sci USA 105, 15136-15141.
72. Browne SE (2008) Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models. Ann NY Acad Sci 1147, 358-382.
73. Damiano M, Galvan L, Deglon N, Brouillet E (2010) Mitochondria in Huntington's disease. Biochim Biophys Acta 1802, 52-61.
74. Brouillet E, Jacquard C, Bizat N, Blum D (2005) 3-Nitropropionic acid: a mitochondrial toxin to uncover phys-iopathological mechanisms underlying striatal degeneration in Huntington's disease. J Neurochem 95, 1521-1540.
75. Diwakarla S, Mercer LD, Kardashsyan L, Chu PW, Shin YS, Lau CL, Hughes ML, Nagley P, Beart PM (2009) GABAer-gic striatal neurons exhibit caspase-independent, mitochon-drially mediated programmed cell death. J Neurochem 109 Suppl 1, 198-206.
76. Benchoua A, Trioulier Y, Zala D, Gaillard MC, Lefort N, Du-four N, Saudou F, Elalouf JM, Hirsch E, Hantraye P, Deglon N, Brouillet E (2006) Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin. Mol Biol Cell 17, 1652-1663.
77. Reddy PH, Mao P, Manczak M (2009) Mitochondrial structural and functional dynamics in Huntington's disease. Brain Res Rev 61, 33-48.
78. Sarkar S, Ravikumar B, Floto RA, Rubinsztein DC (2009) Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine- expanded huntingtin and related proteinopathies. Cell Death Differ 16, 46-56.
79. Borthwick GM, Johnson MA, Ince PG, Shaw PJ, Turnbull DM (1999) Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Ann Neurol 46, 787-790.
80. Mahad DJ, Ziabreva I, Campbell G, Lax N, White K, Hanson PS, Lassmann H, Turnbull DM (2009) Mitochondrial changes within axons in multiple sclerosis. Brain 132, 11611174.
81. Niizuma K, Endo H, Nito C, Myer DJ, Chan PH (2009) Potential role of PUMA in delayed death of hippocampal CA1 neurons after transient global cerebral ischemia. Stroke 40, 618-625.
82. Steckley D, Karajgikar M, Dale LB, Fuerth B, Swan P, Drummond-Main C, Poulter MO, Ferguson SS, Strasser A, Cregan SP (2007) Puma is a dominant regulator of oxida-tive stress induced Bax activation and neuronal apoptosis. J Neurosci 27, 12989-12999.
83. Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI, Adams JM, Huang DC (2005) Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19, 1294-1305.
84. Wyttenbach A, Tolkovsky AM (2006) The BH3-only protein Puma is both necessary and sufficient for neuronal apopto-sis induced by DNA damage in sympathetic neurons. J Neurochem 96, 1213-1226.
85. Fei Q, McCormack AL, Di Monte DA, Ethell DW (2008) Paraquat neurotoxicity is mediated by a Bak-dependent mechanism. J Biol Chem 283, 3357-3364.
86. Beart PM, Lim ML, Chen B, Diwakarla S, Mercer LD, Cheung NS, Nagley P (2007) Hierarchical recruitment by AM-PA but not staurosporine of pro-apoptotic mitochondrial signaling in cultured cortical neurons: evidence for caspase-dependent/independent cross-talk. J Neurochem 103, 24082427.
87. Higgins GC, Beart PM, Nagley P (2009) Oxidative stress triggers neuronal caspase-independent death: endonuclease G involvement in programmed cell death-type III. Cell Mol Life Sci 66, 2773-2787.
88. Valencia A, Moran J (2004) Reactive oxygen species induce different cell death mechanisms in cultured neurons. Free Radic Biol Med 36, 1112-1125.
89. Todde V, Veenhuis M, van der Klei IJ (2009) Autophagy: principles and significance in health and disease. Biochim Biophys Acta 1792, 3-13.
90. Terman A, Gustafsson B, Brunk UT (2006) Mitochondrial damage and intralysosomal degradation in cellular aging. Mol Aspects Med 27, 471-482.
91. Tolkovsky AM (2009) Mitophagy. Biochim Biophys Acta 1793, 1508-1515.
92. Chen H, Chan DC (2009) Mitochondrial dynamics -fusion, fission, movement, and mitophagy -in neurodegenerative diseases. Hum Mol Genet 18, R169-176.
93. Perkins G, Bossy-Wetzel E, Ellisman MH (2009) New insights into mitochondrial structure during cell death. Exp Neurol 218, 183-192.
94. Barsoum MJ, Yuan H, Gerencser AA, Liot G, Kushnareva Y, Graber S, Kovacs I, Lee WD, Waggoner J, Cui J, White AD, Bossy B, Martinou JC, Youle RJ, Lipton SA, Ellisman MH, Perkins GA, Bossy-Wetzel E (2006) Nitric oxide-induced mi-tochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J 25, 3900-3911.
95. Kroemer G, Levine B (2008) Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol 9, 1004-1010.
96. Zhu X, Raina AK, Perry G, Smith MA (2006) Apoptosis in Alzheimer disease: a mathematical improbability. Curr Alzheimer Res 3, 393-396.
97. Raina AK, Hochman A, Zhu X, Rottkamp CA, Nunomu-ra A, Siedlak SL, Boux H, Castellani RJ, Perry G, Smith MA (2001) Abortive apoptosis in Alzheimer's disease. Acta Neuropathol 101, 305-310.
98. Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G, Smith MA, Zhu X, Perry G (2007) Autophagocytosis of mitochondria is prominent in Alzheimer disease. J Neuropathol Exp Neurol 66, 525-532.
99. Zheng L, Roberg K, Jerhammar F, Marcusson J, Terman A (2006) Oxidative stress induces intralysosomal accumulation of Alzheimer amyloid beta-protein in cultured neuroblastoma cells. Ann NY Acad Sci 1067, 248-251.
100. Zheng L, Kagedal K, Dehvari N, Benedikz E, Cowburn R, Marcusson J, Terman A (2009) Oxidative stress induces macroautophagy of amyloid beta-protein and ensuing apop-tosis. Free Radic Biol Med 46, 422-429.
101. Vila M, Ramonet D, Perier C (2008) Mitochondrial alterations in Parkinson's disease: new clues. J Neurochem 107, 317-328.
102. Darios F, Corti O, Lucking CB, Hampe C, Muriel MP, Abbas N, Gu WJ, Hirsch EC, Rooney T, Ruberg M, Brice A (2003) Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum Mol Genet 12, 517-526.
103. Dagda RK, Cherra SJ, 3rd, Kulich SM, Tandon A, Park D, Chu CT (2009) Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol Chem 284, 13843-13855.
104. Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, Klose J, Shen J (2004) Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem 279, 18614-18622.
105. Exner N, Treske B, Paquet D, Holmstrom K, Schiesling C, Gispert S, Carballo-Carbajal I, Berg D, Hoepken HH, Gasser T, Kruger R, Winklhofer KF, Vogel F, Reichert AS, Auburger G, Kahle PJ, Schmid B, Haass C (2007) Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci 27, 12413-12418.
106. Petit A, Kawarai T, Paitel E, Sanjo N, Maj M, Scheid M, Chen F, Gu Y, Hasegawa H, Salehi-Rad S, Wang L, Rogae-va E, Fraser P, Robinson B, St George-Hyslop P, Tandon A (2005) Wild-type PINK1 prevents basal and induced neu-ronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J Biol Chem 280, 34025-34032.
107. Pridgeon JW, Olzmann JA, Chin LS, Li L (2007) PINK1 protects against oxidative stress by phosphorylating mitochon-drial chaperone TRAP1. PLoSBiol 5, e172.
108. Strauss KM, Martins LM, Plun-Favreau H, Marx FP, Kautz-mann S, Berg D, Gasser T, Wszolek Z, Muller T, Bornemann A, Wolburg H, Downward J, Riess O, Schulz JB, Kruger R (2005) Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum Mol Genet 14, 20992111.
109. Plun-Favreau H, Klupsch K, Moisoi N, Gandhi S, Kjaer S, Frith D, Harvey K, Deas E, Harvey RJ, McDonald N, Wood NW, Martins LM, Downward J (2007) The mitochon-drial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol 9, 1243-1252.
110. Yun J, Cao JH, Dodson MW, Clark IE, Kapahi P, Chowd-hury RB, Guo M (2008) Loss-of-function analysis suggests that Omi/HtrA2 is not an essential component of the PINK1/PARKIN pathway in vivo. J Neurosci 28, 1450014510.
111. Narendra D, Tanaka A, Suen DF, Youle RJ (2009) Parkin-induced mitophagy in the pathogenesis of Parkinson disease. Autophagy 5, 706-708.
112. Vives-Bauza C, Zhou C, Huang Y, Cui M, de Vries RL, Kim J, May J, Tocilescu MA, Liu W, Ko HS, Magrane J, Moore DJ, Dawson VL, Grailhe R, Dawson TM, Li C, Tieu K, Przedborski S PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A 107, 378-383.
113. Whitworth AJ, Pallanck LJ (2009) The PINK1/Parkin pathway: a mitochondrial quality control system? J Bioenerg Biomembr 41, 499-503.
114. Taira T, Saito Y, Niki T, Iguchi-Ariga SM, Takahashi K, Ariga H (2004) DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 5, 213-218.
115. Lavara-Culebras E, Paricio N (2007) Drosophila DJ-1 mutants are sensitive to oxidative stress and show reduced lifespan and motor deficits. Gene 400, 158-165.
116. Zhou W, Freed CR (2005) DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alphα-synuclein toxicity. J Biol Chem 280, 43150-43158.
117. Yokota T, Sugawara K, Ito K, Takahashi R, Ariga H, Mizu-sawa H (2003) Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem Biophys Res Commun 312, 1342-1348.
118. Baulac S, Lu H, Strahle J, Yang T, Goldberg MS, Shen J, Schlossmacher MG, Lemere CA, Lu Q, Xia W (2009) Increased DJ-1 expression under oxidative stress and in Alzheimer's disease brains. Mol Neurodegener 4, 12.
119. Nakka VP, Gusain A, Mehta SL, Raghubir R (2008) Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities. Mol Neurobiol 37, 7-38.
120. Scherz-Shouval R, Elazar Z (2007) ROS, mitochondria and the regulation of autophagy. Trends Cell Biol 17, 422-427.
121. Kirkland RA, Adibhatla RM, Hatcher JF, Franklin JL (2002) Loss of cardiolipin and mitochondria during programmed neuronal death: evidence of a role for lipid peroxidation and autophagy. Neuroscience 115, 587-602.
122. Cheung EC, Joza N, Steenaart NA, McClellan KA, Neuspiel M, McNamara S, MacLaurin JG, Rippstein P, Park DS, Shore GC, McBride HM, Penninger JM, Slack RS (2006) Dissociating the dual roles of apoptosis-inducing factor in maintaining mitochondrial structure and apoptosis. EMBO J 25, 4061-4073.
123. Cregan SP, Fortin A, MacLaurin JG, Callaghan SM, Cecconi F, Yu SW, Dawson TM, Dawson VL, Park DS, Kroemer G, Slack RS (2002) Apoptosis-inducing factor is involved in the regulation ofcaspase-independent neuronal cell death. J Cell Biol 158, 507-517.
124. Klein JA, Longo-Guess CM, Rossmann MP, Seburn KL, Hurd RE, Frankel WN, Bronson RT, Ackerman SL (2002) The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 419, 367-374.
125. Beckman J, Beckman T, Chen J, Marshall P, Freeman B (1990) Apparent hydroxyl radical production by peroxyni-trite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87, 1620-1624.
126. Vignais P (2002) The superoxide-generating NADPH oxi-dase: structural aspects and activation mechanism. Cell Mol Life Sci 59, 1428-1459.
127. Halliwell B, Gutteridge J (1999) Free Radicals in Biology and Medicine, Oxford University Press, Oxford.
128. Babior BM (2000) Phagocytes and oxidative stress. Am J Med 109, 33-44.
129. Hussien M, Delecata RJ, Carey PD (2002) Neutrophil hypochlorous acid production is impaired in multiple organ failure patients with candidaemia; reversal with antifungal agents. Inflamm Res 51, 213-217.
130. King CC, Jefferson MM, Thomas EL (1997) Secretion and inactivation of myeloperoxidase by isolated neutrophils. J Leukoc Biol 61, 293-302.
131. Eiserich J, Cross C, Jones A, Halliwell B, Vliet Avd (1996) Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification. J Biol Chem 271, 19199-19208.
132. Guix F, Uribesalgo I, Coma M, Munoz F (2005) The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol 76, 126-152.
133. Iadecola C, Zhang F, Xu S, Casey R, Ross M (1995) In-ducible nitric oxide synthase gene expression in brain following cerebral ischemia. J Cereb Blood Flow Metab 15, 378-384.
134. Beckman J, Koppenol W (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271, C1424-C1437.
135. Brown G (1999) Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1411, 351-369.
136. Chinopoulos C, Adam-Vizi V (2006) Calcium, mitochondria and oxidative stress in neuronal pathology. Novel aspects of an enduring theme. FEBSJ 273, 433-450.
137. McMahon M, Itoh K, Yamamoto M, Chanas S, Henderson C, McLellan L, Wolf C, Cavin C, Hayes J (2001) The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glu-tathione biosynthetic enzymes. Cancer Res 61, 3299-3307.
138. Johnson J, Johnson D, Kraft A, Calkins M, Jakel R, Vargas M, Chen P (2008) The Nrf2 -ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann NY Acad Sci 1147: 61-69
139. Zhao J, Moore AN, Redell JB, Dash PK (2007) Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury. J Neurosci 27, 10240-10248.
140. Kaspar JW, Niture SK, Jaiswal AK (2009) Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 47, 1304-1309.
141. Wilce MC, Parker MW (1994) Structure and function of glutathione S-transferases. Biochim Biophys Acta 1205, 1-18.
142. Faig M, Bianchet MA, Talalay P, Chen S, Winski S, Ross D, Amzel LM (2000) Structures of recombinant human and mouse NAD(P)H:quinone oxidoreductases: species comparison and structural changes with substrate binding and release. Proc Natl Acad Sci USA 97, 3177-3182.
143. Liu ZJ, Sun YJ, Rose J, Chung YJ, Hsiao CD, Chang WR, Kuo I, Perozich J, Lindahl R, Hempel J, Wang BC (1997) The first structure of an aldehyde dehydrogenase reveals novel interactions between NAD and the Rossmann fold. Nat Struct Biol 4,317-326.
144. Wasserman W, Fahl W (1997) Comprehensive analysis of proteins which interact with the antioxidant responsive element: correlation of ARE-BP-1 with the chemoprotective induction response. Arch Biochem Biophys 344, 387-396.
145. Gorlach A, Klappa P, Kietzmann T (2006) The endoplas-mic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid Redox Signal 8, 1391-1418.
146. Schroder M (2008) Endoplasmic reticulum stress responses. Cell Mol Life Sci 65, 862-894.
147. Harding H, Zhang Y, Ron D (1999) Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397, 271-274.
148. Sanden MVD, Houweling M, Golde Lv, Vaandrager A (2003) Inhibition of phosphatidylcholine synthesis induces expression of the endoplasmic reticulum stress and apoptosis-related protein CCAAT/enhancer-binding protein-homologous protein (CHOP/GADD153). Biochem J 369, 643-650.
149. Wang K (2000) Calpain and caspase: can you tell the difference? Trends Neurosci 23, 20-26.
150. Schroder M, Kaufman R (2005) ER stress and the unfolded protein response. Mutat Res 569, 29-63.
151. Gaczynska M, Osmulski P, Ward W (2001) Caretaker or undertaker? The role of the proteasome in aging. Mech Ageing Dev 122, 235-254.
152. Mandel S, Grunblatt E, Riederer P, Amariglio N, Jacob-Hirsch J, Rechavi G, Youdim M (2005) Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70. AnnN YAcad Sci 1053, 356-375.
153. Yew E, Cheung N, Choy M, Qi R, Lee A, Peng Z, Melen-dez A, Manikandan J, Koay E, Chiu L, Ng W, Whiteman M, Kandiah J, Halliwell B (2005) Proteasome inhibition by lactacystin in primary cortical neuronal cells induces both potentially neuroprotective and proapoptotic transcriptional responses: a microarray analysis. J Neurochem 94, 943-956.
154. Santo-Domingo J, Demaurex N (2010) Calcium uptake mechanisms of mitochondria. Biochim Biophys Acta, in press.
155. Crocker S, Smith P, Jackson-Lewis V, Lamba W, Hayley S, Grimm E, Callaghan S, Slack R, Melloni E, Przedborski S, Robertson G, Anisman H, Merali Z, Park D (2003) Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J Neurosci 23, 4081-4091.
156. Donato R (2001) S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33, 637-668.
157. Chen M, Yap Y, Choy M, Koh C, Seet S, Duan W, Whiteman M, Cheung N (2006) Early induction of calpains in rotenone-mediated neuronal apoptosis. Neurosci Lett 397, 69-73.
158. Peng Z, Chen M, Yap Y, Manikandan J, Melendez A, Choy M, Moore P, Cheung N (2008) Proteasome inhibition: an early or late event in nitric oxide-induced neuronal death? Nitric Oxide 18, 136-145.
159. Yap Y, Whiteman M, Bay B, Li Y, Sheu F, Qi R, Tan C, Cheung N (2006) Hypochlorous acid induces apoptosis of cultured cortical neurons through activation of calpains and rupture of lysosomes. J Neurochem 98, 1597-1609.
160. Chua B, Guo K, Li P (2000) Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases. J Biol Chem 275, 5131-5135.
161. Murphy MP, Smith RA (2007) Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 47, 629-656.
162. Szeto HH (2008) Mitochondria-targeted cytoprotective pep-tides for ischemia-reperfusion injury. Antioxid Redox Signal 10, 601-619.
163. Dennis GJ, Sherman B, Hosack D, Yang J, Gao W, Lane H, Lempicki R (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4, P3.
164. Huang D, Sherman B, Lempicki R (2009) Systematic and integrative analysis of large gene lists using DAVID Bioin-formatics Resources. Nature Protoc 4, 44-57.
165. Carroll FY, Beart PM, Cheung NS (1996) NMDA-mediated activation of the NO/cGMP pathway: characteristics and regulation in cultured neocortical neurones. J Neurosci Res 43, 623-631.